Have cancer? Immunosuppressed? “You can have your second dose in four months.” Preliminary study reports cancer patients’ immune response is less protective after first dose vs. healthy people. Dosing delay needs to be reviewed for vulnerable groups.

Sunday House Call, #785, April 11, 2021

Topics today include:
Cancer patients could be at risk if second doses delayed beyond three weeks, experts say

Interim results of the safety and immune-efficacy of 1 versus 2 doses of COVID-19 vaccine BNT162b2 for cancer patients in the context of the UK vaccine priority guidelines

Your calls about:

  • The four-month Covid vaccine second dose delay
  • Anticoagulant medication and Covid vaccine
  • Management choices for supraventricular tachycardia (rapid heart rhythm abnormality) for a 90 year-old man
  • Arranging the first dose of an immunosuppressant medication for a woman in home palliative care
  • Vitamin K2
  • A woman on antiarrhythmic medications is experiencing fatigue that occurs at 4PM everyday
  • What are the recommendations for Covid vaccine if you have Protein S Deficiency?